Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
Interleukins
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
fletikumab
(NNC109-0012) / Novo Nordisk
Arcalyst
(rilonacept) / Regeneron, Kiniksa
NN9828
/ Almirall
Proleukin
(aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
Stelara
(ustekinumab) / J&J
Taltz
(ixekizumab) / Eli Lilly, Japan Tobacco
gevokizumab
(VPM087) / Novartis
vobarilizumab
(ALX-0061) / Sanofi
AMG 108
/ AstraZeneca
Artlegia
(olokizumab) / R-Pharm
Rizaben
(tranilast) / Kissei, Nuon Therapeutics
TOUR006
/ Tourmaline Bio
piclidenoson
(CF101) / Can-Fite
GSK315234
/ GSK
LY 2189102
/ Eli Lilly
Ozespa
(briakinumab) / AbbVie
Tremfya
(guselkumab) / J&J
apilimod
(STA-5326) / Madrigal Pharma
diacerein
/ Generic mfg.
vidofludimus
(IMU-838) / Immunic
